<?xml version="1.0" encoding="UTF-8"?>
<references>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:52:11Z</created-at>
    <id type="integer">229</id>
    <position type="integer">1</position>
    <text>&lt;http://www.mhra.gov.uk/&gt;.  Report of the CSM Expert Working Group on the safety of selective serotonin reuptake inhibitor antidepressants.  6 December 2004.</text>
    <updated-at type="datetime">2007-01-05T13:52:11Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:52:24Z</created-at>
    <id type="integer">230</id>
    <position type="integer">2</position>
    <text>[Management of depression in primary and secondary care](http://www.nice.org.uk/CG023NICEguideline).  Clinical Guideline 23.  6 December 2004.</text>
    <updated-at type="datetime">2007-01-05T13:52:24Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:52:38Z</created-at>
    <id type="integer">231</id>
    <position type="integer">3</position>
    <text>Van Walraven C, Mamdani MM, Wells PS, Williams JI.  Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. *BMJ* 2001; **323:**655&#8211;8.</text>
    <updated-at type="datetime">2007-01-05T13:52:38Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:52:50Z</created-at>
    <id type="integer">232</id>
    <position type="integer">4</position>
    <text>Moses-Kelko EL, Bogen D, Perel J *et al*.  Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications.  *JAMA* 2005; **293:**2372 83.</text>
    <updated-at type="datetime">2007-01-05T13:52:50Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:53:00Z</created-at>
    <id type="integer">233</id>
    <position type="integer">5</position>
    <text>National Teratology Information Service (NTIS), Regional Drug and Therapeutics Centre, Newcastle.  Use of paroxetine in pregnancy.  28 Sept 2005.</text>
    <updated-at type="datetime">2007-01-05T13:53:00Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:53:12Z</created-at>
    <id type="integer">234</id>
    <position type="integer">6</position>
    <text>Chambers CD, Hernandez-Diaz S, Van Marter LJ *et al*.  Selective serotonin re-uptake inhibitors and risk of persistent pulmonary hypertension of the newborn. *New Engl J Med* 2006; **354:**579-87.</text>
    <updated-at type="datetime">2007-01-05T13:53:12Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:53:24Z</created-at>
    <id type="integer">235</id>
    <position type="integer">7</position>
    <text>Cipriani A, Barbui C, Geddes JR.  Suicide, depression and antidepressants. Editorial.  *BMJ* 2005; **330:**373-4.</text>
    <updated-at type="datetime">2007-01-05T13:53:24Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:53:35Z</created-at>
    <id type="integer">236</id>
    <position type="integer">8</position>
    <text>Simon GE, Savarino J, Operskalski B, Wang PS.  Suicide risk during antidepressant treatment.  *Am J Psychiatr* 2006; **163:**41-7.</text>
    <updated-at type="datetime">2007-01-05T13:53:35Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:53:47Z</created-at>
    <id type="integer">237</id>
    <position type="integer">9</position>
    <text>Juurlink DN, Mamdani MM, Kopp A, Redelmeier DA.  The risk of suicide with selective serotonin reuptake inhibitors in the elderly.  *Am J Psychiatr* 2006; **163:**813-21.</text>
    <updated-at type="datetime">2007-01-05T13:53:47Z</updated-at>
  </reference>
  <reference>
    <article-id type="integer">21</article-id>
    <created-at type="datetime">2007-01-05T13:54:00Z</created-at>
    <id type="integer">238</id>
    <position type="integer">10</position>
    <text>Committee on Safety of Medicines.  Selective serotonin reuptake inhibitors &#8211; use in children and adolescents with major depressive disorder.  10 December 2003.</text>
    <updated-at type="datetime">2007-01-05T13:54:00Z</updated-at>
  </reference>
</references>
